Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

Journal:
The Lancet Psychiatry
Published:
DOI:
10.1016/s2215-0366(25)00129-4
Affiliations:
10
Authors:
14
Go to article
Institutions Authors Share
Queensland Centre for Mental Health Research (QCMHR), UQ, Australia
3.500000
 0.25
Metro South Health, Australia
3.000000
 0.21
The University of Queensland (UQ), Australia
2.500000
 0.18
Swinburne University of Technology, Australia
1.000000
 0.07
QIMR Berghofer Medical Research Institute, Australia
1.000000
 0.07
West Moreton Health, Australia
1.000000
 0.07
Centre for Children’s Health Research (CCHR), Australia
0.500000
 0.04
Alfred Health, Australia
0.500000
 0.04
Monash University, Australia
0.500000
 0.04
The Prince Charles Hospital (TPCH), Australia
0.500000
 0.04
Interested in Clinical Sciences?